The 2017 Annual Report of the State Agency of Medicines
| | The 2017 Annual Report of the State Agency of Medicines The State Agency of Medicines (SAM) has published its Annual Report of the year 2017 which summarizes information regarding the operation of the Agency during the previous year.
Some of the numbers that show Agency’s achievements last year: - marketing authorisations were issued for 254 new medicines,
- SAM carried out a total of 182 medicines renewal procedures,
- issued 7248 authorisations for import, export, transit and distribution of medicines,
- 50 authorisations issued for conduct of clinical trials,
- 278 clinical trials took place in Latvia in 2017,
- 588 adverse drug reaction reports were received,
- the Laboratory tested 119 samples of medicines; 97 samples of purified water produced in pharmacies were selected and tested, 349 volumetric solutions, indicators and reagents were prepared,
- 253 announcements of medical devices placement on the market were received and information on them was entered in LATMED medical device database,
- 218 Certificates of Pharmaceutical Product and 30 Certificates of Free Sale were issued,
- 343 licences for the activity of pharmacies, 46 licences for medicines wholesalers, 19 licences for medicines manufacturing or import and 4 licenses for manufacturing of the active substances were issued,
- 17 permits for utilisation of tissues and cells were issued to tissue centres and one permit – to a higher education institution, including 14 related to changes in activity,
- 24 compliance certificates were issued to blood establishments and blood banks.
The 2017 Annual Report of the State Agency of Medicines is available in the section “Publications” on the SAM website. |
